112 related articles for article (PubMed ID: 27250585)
1. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.
Maruyama H; Katagiri T; Kashiwase K; Shiina T; Sato-Otsubo A; Zaimoku Y; Maruyama K; Hosokawa K; Ishiyama K; Yamazaki H; Inoko H; Ogawa S; Nakao S
Exp Hematol; 2016 Oct; 44(10):931-939.e3. PubMed ID: 27250585
[TBL] [Abstract][Full Text] [Related]
2. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
[TBL] [Abstract][Full Text] [Related]
3. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
4. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
5. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
Huang YL; Huang SL; Huang K; Bao R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
[TBL] [Abstract][Full Text] [Related]
6. Association of aplastic anemia and FoxP3 gene polymorphisms in Koreans.
In JW; Lee N; Roh EY; Shin S; Park KU; Song EY
Hematology; 2017 Apr; 22(3):149-154. PubMed ID: 27702400
[TBL] [Abstract][Full Text] [Related]
7. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.
Zaimoku Y; Takamatsu H; Hosomichi K; Ozawa T; Nakagawa N; Imi T; Maruyama H; Katagiri T; Kishi H; Tajima A; Muraguchi A; Kashiwase K; Nakao S
Blood; 2017 May; 129(21):2908-2916. PubMed ID: 28232583
[TBL] [Abstract][Full Text] [Related]
8. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.
Betensky M; Babushok D; Roth JJ; Mason PJ; Biegel JA; Busse TM; Li Y; Lind C; Papazoglou A; Monos D; Podsakoff G; Bessler M; Olson TS
Cancer Genet; 2016; 209(1-2):1-10. PubMed ID: 26702937
[TBL] [Abstract][Full Text] [Related]
9. Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms and childhood susceptibility to acquired aplastic anemia.
Chen C; Lu S; Luo M; Zhang B; Xiao L
Acta Haematol; 2012; 128(1):23-7. PubMed ID: 22572536
[TBL] [Abstract][Full Text] [Related]
10. [A loss-of-function mutation in exon1 of limited HLA class I alleles is common in patients with aplastic anemia].
Mizumaki H
Rinsho Ketsueki; 2021; 62(4):270-277. PubMed ID: 33967152
[TBL] [Abstract][Full Text] [Related]
11. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
Song EY; Kang HJ; Shin HY; Ahn HS; Kim I; Yoon SS; Park S; Kim BK; Park MH
Hum Immunol; 2010 Jan; 71(1):88-92. PubMed ID: 19819281
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of acquired aplastic anaemia in adults: 142 cases from a multicentre, prospective cohort study in Shanghai, China.
Wang W; Wang X; Xu X; Lin G
J Int Med Res; 2011; 39(5):1994-2005. PubMed ID: 22118004
[TBL] [Abstract][Full Text] [Related]
13. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
[TBL] [Abstract][Full Text] [Related]
14. Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin.
Nakao S; Takami A; Sugimori N; Ueda M; Shiobara S; Matsuda T; Mizoguchi H
Br J Haematol; 1996 Jan; 92(1):155-8. PubMed ID: 8562389
[TBL] [Abstract][Full Text] [Related]
15. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of detecting human leukocyte antigen class I allele-lacking leukocytes in aplastic anemia].
Hosokawa K; Nakao S
Rinsho Ketsueki; 2022; 63(8):899-905. PubMed ID: 36058861
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between polymorphism of HLA-A, -B, -DRB1 alleles and susceptibility of children to acquired aplastic anemia].
Lu SY; Xiao LL; Luo M; Zhang BH; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):120-4. PubMed ID: 22391180
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis-associated aplastic anemia.
Brown KE; Tisdale J; Barrett AJ; Dunbar CE; Young NS
N Engl J Med; 1997 Apr; 336(15):1059-64. PubMed ID: 9091802
[TBL] [Abstract][Full Text] [Related]
19. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
[TBL] [Abstract][Full Text] [Related]
20. The frequency of HLA class I and II alleles in Pakistani patients with aplastic anemia.
Rehman S; Saba N; Khalilullah ; Munir S; Ahmed P; Mehmood T
Immunol Invest; 2009; 38(8):812-9. PubMed ID: 19860590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
